Best Practice & Research Clinical Rheumatology
Volume 21, Issue 4 , Pages 699-712 , August 2007

Assessments in ankylosing spondylitis

  • Jane Zochling, MBBS, MMed (ClinEpi), PhD (Postdoctoral Research Fellow)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +61 3 62267737; Fax: +61 3 62267704.

References 

  1. van der Heijde D, Bellamy N, Calin A, et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. The Journal of Rheumatology. 1997;24:2225–2229
  2. van der Heijde D, van der Linden S, Dougados M, et al. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. The Journal of Rheumatology. 1999;26:1003–1005
  3. van der Heijde D, van der Linden S, Bellamy N, et al. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. The Journal of Rheumatology. 1999;26:945–947
  4. van der Heijde D, Calin A, Dougados M, et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. The Journal of Rheumatology. 1999;26:951–954
  5. Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases. 2006;65:442–452
  6. Braun J, Pham T, Sieper J, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 2003;62:817–824
  7. Braun J, Davis J, Dougados M, et al. First update of the International ASAS Consensus Statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 2006;65:316–320
  8. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). British Journal of Rheumatology. 1996;35:66–71
  9. Pavy S, Brophy S, Calin A. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study. The Journal of Rheumatology. 2005;32:80–85
  10. van Tubergen A, Debats I, Ryser L, et al. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis and Rheumatism. 2002;47:242–248
  11. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis and Rheumatism. 2006;54:569–578
  12. Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. European Journal of Pain (London, England). 2004;8:283–291
  13. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. The Journal of Rheumatology. 1994;21:2286–2291
  14. Anderson JJ, Baron G, van der Heijde D, et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis and Rheumatism. 2001;44:1876–1886
  15. Haywood KL, Garratt AM, Jordan K, et al. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford, England). 2004;43:750–757
  16. Viitanen JV, Heikkila S, Kokko ML, Kautiainen H. Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials?. Clinical Rheumatology. 2000;19:131–137
  17. Viitanen JV, Kokko ML, Heikkila S, Kautiainen H. Neck mobility assessment in ankylosing spondylitis: a clinical study of nine measurements including new tape methods for cervical rotation and lateral flexion. British Journal of Rheumatology. 1998;37:377–381
  18. Viitanen JV, Kautiainen H, Suni J, et al. The relative value of spinal and thoracic mobility measurements in ankylosing spondylitis. Scandinavian Journal of Rheumatology. 1995;24:94–97
  19. Moll JM, Wright V. The pattern of chest and spinal mobility in ankylosing spondylitis. An objective clinical study of 106 patients. Rheumatology and Rehabilitation. 1973;12:115–134
  20. Macrae IF, Wright V. Measurement of back movement. Annals of the Rheumatic Diseases. 1969;28:584–589
  21. Macrae IF, Wright V. Measurement of lumbar spine motion in population studies. Annals of the Rheumatic Diseases. 1969;28:329
  22. Braun J, Cook R, Gladman D, et al. INSPIRE Lateral Flexion: a new method to measure lateral spinal mobility in patients with spondyloarthritis (abstract). Arthritis and Rheumatism. 2006;54:S476
  23. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. The Journal of Rheumatology. 1994;21:1694–1698
  24. Heuft-Dorenbosch L, Vosse D, Landewe R, et al. Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. The Journal of Rheumatology. 2004;31:1779–1784
  25. Heikkila S, Viitanen JV, Kautiainen H, Kauppi M. Sensitivity to change of mobility tests; effect of short term intensive physiotherapy and exercise on spinal, hip, and shoulder measurements in spondyloarthropathy. The Journal of Rheumatology. 2000;27:1251–1256
  26. Rahali-Khachlouf H, Poiraudeau S, Fermanian J, et al. Validity and reliability of spinal clinical measures in ankylosing spondylitis. Annales de réadaptation et de médecine physique. 2001;44:205–212
  27. Kennedy LG, Jenkinson TR, Mallorie PA, et al. Ankylosing spondylitis: the correlation between a new metrology score and radiology. British Journal of Rheumatology. 1995;34:767–770
  28. Wanders A, Landewé R, Dougados M, et al. Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?. Annals of the Rheumatic Diseases. 2005;64:988–994
  29. van der Heijde D, Dijkmans B, Geusens P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis. Results of a randomized controlled trial (ASSERT). Arthritis and Rheumatism. 2005;52:582–591
  30. van Echteld I, Cieza A, Boonen A, et al. Identification of the most common problems in patients with ankylosing spondylitis using the International Classification of Functioning, Disability and Health. The Journal of Rheumatology. 2006;33:2475–2483
  31. Zochling J, Grill E, Scheuringer M, et al. Identification of health problems in patients with acute inflammatory arthritis, using the International Classification of Functioning, Disability and Health (ICF). Clinical and Experimental Rheumatology. 2006;24:239–246
  32. Sigl T, Cieza A, van der Heijde D, Stucki G. ICF-based comparison of disease-specific instruments measuring physical functional ability for ankylosing spondylitis. Annals of the Rheumatic Diseases. 2005;64:1576–1581
  33. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. The Journal of Rheumatology. 1994;21:2281–2285
  34. Dougados M, Gueguen A, Nakache JP, et al. Evaluation of a functional index for patients with ankylosing spondylitis. The Journal of Rheumatology. 1990;17:1254–1255
  35. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology (Oxford, England). 2004;43:1565–1568
  36. Balint PV, Kane D, Wilson H, et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Annals of the Rheumatic Diseases. 2002;61:905–910
  37. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Annals of the Rheumatic Diseases. 2003;62:127–132
  38. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002;359:1187–1193
  39. Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. The Journal of Rheumatology. 1994;21:1227–1237
  40. Dougados M, Gueguen A, Nakache JP, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. The Journal of Rheumatology. 1999;26:971–974
  41. Dougados M, Revel M, Khan MA. Spondyloarthropathy treatment: progress in medical treatment, physical therapy and rehabilitation. Baillière's Clinical Rheumatology. 1998;12:717–736
  42. Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. The Journal of Rheumatology. 1999;26:980–984
  43. Ruof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. The Journal of Rheumatology. 1999;26:966–970
  44. Jones SD, Koh WH, Steiner A, et al. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. The Journal of Rheumatology. 1996;23:487–490
  45. van Tubergen A, Coenen J, Landewe R, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis and Rheumatism. 2002;47:8–16
  46. Calin A, Edmunds L, Kennedy LG. Fatigue in ankylosing spondylitis–why is it ignored?. The Journal of Rheumatology. 1993;20:991–995
  47. Dernis-Labous E, Messow M, Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology (Oxford, England). 2003;42:1523–1528
  48. Heiberg MS, Nordvag BY, Mikkelsen K, et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis and Rheumatism. 2005;52:2506–2512
  49. Cella D, Lai JS, Chang CH, et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528–538
  50. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research. 1995;39:315–325
  51. Dagfinrud H, Vollestad NK, Loge JH, et al. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures. Arthritis and Rheumatism. 2005;53:5–11
  52. Zochling J, van der Heijde D, Dougados M, Braun J. Current evidence for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases. 2006;65:423–432
  53. Creemers MCW, Franssen MJAM, van 't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Annals of the Rheumatic Diseases. 2005;64:127–129
  54. Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheumatic Diseases Clinics of North America. 1998;24:697–735
  55. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis and Rheumatism. 1994;37:1039–1045
  56. Zochling J, Braun J. Remission in ankylosing spondylitis. Clinical and Experimental Rheumatology. 2006;24:S088–S092
  57. Calin A, Nakache JP, Gueguen A, et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?. Rheumatology (Oxford, England). 1999;38:878–882
  58. Haywood KL, Garratt AM, Dawes PT. Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford, England). 2005;44:577–586
  59. Cohen JD, Cunin P, Farrenq V, et al. Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies. The Journal of Rheumatology. 2006;33:79–81
  60. Breban M, Vignon E, Claudepierre P, et al. Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology. 2002;41:1280–1285
  61. Ward MM. Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?. Annals of the Rheumatic Diseases. 2006;65(supplement 3):iii25–iii28

PII: S1521-6942(07)00031-9

doi: 10.1016/j.berh.2007.02.010

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 4 , Pages 699-712 , August 2007

Article Tools